Cargando…

1655 Lack of Adherence to SHEA-IDSA Treatment Guidelines for Severe Clostridium difficile Infection is Associated with Increased Mortality

Detalles Bibliográficos
Autores principales:	Patel, Ishan, Wungjiranirun, Manida, Theethira, Thimmaiah, Villafuerte, Javier, Leffler, Daniel, Kelly, Ciaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782315/ http://dx.doi.org/10.1093/ofid/ofu052.1201

Ejemplares similares

Discordance of SHEA/IDSA Clostridium difficile Disease Severity Scale in Solid Organ Transplant Patients
por: Lee, Tiffany, et al.
Publicado: (2017)

1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014)

489. Validation of the SHEA/IDSA Severity Criteria to Predict Poor Outcomes Among Inpatients and Outpatients With Clostridium difficile Infection
por: Stevens, Vanessa, et al.
Publicado: (2018)

1624 Risk Factors for Hospital-Acquired Clostridium difficile
por: Knepper, Bryan, et al.
Publicado: (2014)

525 Epidemiology and burden of recurrent Clostridium difficile infections
por: Sheitoyan-Pesant, Caroline, et al.
Publicado: (2014)

Navigating the 2021 update to the IDSA/SHEA Clostridioides difficile guidelines: An ethical approach to equitable patient care
por: Shoff, Christopher J., et al.
Publicado: (2022)

71 Alterations in the Gut Microbiome in Recurrent Clostridium difficile Infection
por: Wang, Gary, et al.
Publicado: (2014)

1628 Accuracy of Healthcare Facility-Onset Clostridium difficile Classification
por: Trappler, Regan, et al.
Publicado: (2014)

1634 Clinical Characteristics of Relapses AND Reinfections in Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2014)

1626 The relationship of Bristol Stool Scale to Clostridium difficile infection
por: Caroff, Daniel, et al.
Publicado: (2014)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

1649 Acquisition of Clostridium difficile Associated with Potentially Contaminated Inpatient Rooms
por: Williams, Catherine, et al.
Publicado: (2014)

1673 Microbial and Inflammatory Markers for Fatal Clostridium difficile Associated Diarrhea
por: Jiang, Zhi-Dong, et al.
Publicado: (2014)

1620 Extraintestinal Clostridium difficile infections: A Single Center Experience
por: Gupta, Arjun, et al.
Publicado: (2014)

1644 Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Crews, Jonathan, et al.
Publicado: (2014)

1660 Risk of Recurrent Clostridium difficile Infection: Impact of Diagnostics and Treatment
por: Reddy, Sujan C., et al.
Publicado: (2014)

1798 Oral, Frozen Fecal Microbiota Capsules for Relapsing Clostridium difficile Infection
por: Youngster, Ilan, et al.
Publicado: (2014)

467 Analysis of Clinical and Economical Outcomes of Fidaxomicin Use for Clostridium difficile infections
por: Flaherty, Sarah, et al.
Publicado: (2014)

1641 Evaluation of Co-Infections among Patients with Community-Associated Clostridium difficile Infection
por: Cohen, Jessica, et al.
Publicado: (2014)

527 Age-Related Changes in the Incidence of Community-Associated Clostridium Difficile Infection (CDI)
por: Faden, Howard
Publicado: (2014)

445 Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

1623 Ertapenem is Associated with an Increased Risk of Clostridium difficile Infections Among Surgical Patients
por: Lee, Seungwon, et al.
Publicado: (2014)

1629 The Incidence of Clostridium difficile Infection in Hospitalized Patients with Cystic Fibrosis in the United States
por: Deshpande, Abhishek, et al.
Publicado: (2014)

1633 The Importance of Considering Different Healthcare Settings When Estimating the Incidence of Clostridium difficile
por: Kuntz, Jennifer, et al.
Publicado: (2014)

1632 Preventon of Clostridium Difficile Infection: A Human Factors and Systems Engineering Approach
por: Yanke, Eric, et al.
Publicado: (2014)

973 Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients
por: Stevens, Vanessa, et al.
Publicado: (2014)

1643 Clostridium difficile Infection Related Emergency Department Visits in the United States 2006-2009
por: Deshpande, Abhishek, et al.
Publicado: (2014)

1622 Statin Use and Hospital-onset Clostridium difficile Infection; A Case Control Study
por: Elashery, Ahmad Ramy
Publicado: (2014)

1647 Are Hospital Floors an Underappreciated Reservoir for Transmission of Clostridium difficile and Methicillin-Resistant Staphylococcus aureus?
por: Deshpande, Abhishek, et al.
Publicado: (2014)

438 Genetic Variants Associated with the Development of Clostridium Difficile Infection during Autologous Stemcell Transplantation
por: Apewokin, Senu, et al.
Publicado: (2014)

1794 Appropriate Antibiotic Therapy is Associated with Reduced Risk of Community Acquired Clostridium difficile Infection
por: Ge, Ivy Y., et al.
Publicado: (2014)

190 Adequacy of Prior Antibiotic Use in Patients with Clostridium difficile Infection: A Resptrospective Analysis
por: Lam, Stefanie, et al.
Publicado: (2014)

461 Clostridium difficile Infection and Mortality in Lung Transplant Recipients: A Single-Center Retrospective Cohort Study
por: Chong, Pearlie P., et al.
Publicado: (2014)

1796 Recovery of Clostridium difficile, Vancomycin Resistant Enterococcus and Methicillin Resistant Staphylococcus aureus from the Food of Hospitalized Patients
por: Kwon, Jennie H., et al.
Publicado: (2014)

529 Frequent Transmission of Clostridium Difficile by Asymptomatically Colonized Long-term Care Facility Residents during Hospital Admissions
por: Donskey, Curtis J., et al.
Publicado: (2014)

453 Association of Clostridium difficile Infection (CDI) with Excess Mortality after Liver Transplantation (LT) for Hilar Cholangiocarcinoma (CCA)
por: Ramanan, Poornima, et al.
Publicado: (2014)

1659 Relapse vs Reinfection. Evaluation of Clostridium difficile Isolates from Incident and Recurrent Infections, Minnesota 2009-2011
por: Whitten, Tory, et al.
Publicado: (2014)

Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines
por: Bishop, Emma Jane, et al.
Publicado: (2022)

1621 US Costs and Outcomes Associated with Clostridium difficile Infections: a Systematic Literature Review, Meta-analysis, and Mathematical Model
por: Schweizer, Marin, et al.
Publicado: (2014)

1645 Do asymptomatic carriers of toxigenic Clostridium difficile identified through inappropriate testing represent a significant risk for transmission?
por: Kundrapu, Sirisha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2c7k5emn63ei3mh8vgmsopmpqs